XML 64 R23.htm IDEA: XBRL DOCUMENT v3.2.0.727
Collaboration Agreement (Tables)
6 Months Ended
Jun. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Potential Milestone Payments in Sales

The triggering events for the sales milestone payments are as follows:

 

Annual Global Net Sales in a Calendar Year

   Milestone Payment(1)  

$400 million

       (2) 

$800 million

       (3) 

$1.2 billion

   $ 70 million   

$1.6 billion

   $ 175 million   

 

(1) Each milestone shall only be paid once during the term of the Astellas Collaboration Agreement.
(2) This milestone totaling $25.0 million was earned and recognized as collaboration revenue during the fourth quarter of 2013 and payment was received in the first quarter of 2014.
(3) This milestone totaling $50.0 million was earned and recognized as collaboration revenue during the fourth quarter of 2014 and is included in receivable from collaboration partner on the consolidated balance sheet at December 31, 2014. Payment was received during the first quarter of 2015.
Schedule of Collaboration Revenue

Collaboration revenue was as follows:

 

     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2015      2014      2015      2014  

Collaboration revenue:

           

Related to U.S. XTANDI net sales

   $ 149,220       $ 71,866       $ 261,230       $ 134,091   

Related to ex-U.S. XTANDI net sales

     25,591         9,992         41,358         15,723   

Related to upfront and milestone payments

     846         66,232         2,257         85,465   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 175,657       $ 148,090       $ 304,845       $ 235,279   
  

 

 

    

 

 

    

 

 

    

 

 

 
Schedule of Collaboration Revenue Related to U.S. XTANDI Net Sales

Collaboration revenue related to U.S. XTANDI net sales was as follows:

 

     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2015      2014      2015      2014  

U.S. XTANDI net sales (as reported by Astellas)

   $ 298,440       $ 143,732       $ 522,460       $ 268,183   

Shared U.S. development and commercialization costs

     (84,947      (70,543      (195,260      (148,250
  

 

 

    

 

 

    

 

 

    

 

 

 

Pre-tax U.S. profit

   $ 213,493       $ 73,189       $ 327,200       $ 119,933   
  

 

 

    

 

 

    

 

 

    

 

 

 

Medivation’s share of pre-tax U.S. profit

   $ 106,747       $ 36,594       $ 163,600       $ 59,966   

Reimbursement of Medivation’s share of shared U.S. costs

     42,473         35,272         97,630         74,125   
  

 

 

    

 

 

    

 

 

    

 

 

 

Collaboration revenue related to U.S. XTANDI net sales

   $ 149,220       $ 71,866       $ 261,230       $ 134,091   
  

 

 

    

 

 

    

 

 

    

 

 

 
Schedule of Collaboration Revenue Related to Upfront and Milestone Payments

Collaboration revenue related to upfront and milestone payments from Astellas was as follows:

 

     Three Months Ended
June 30,
     Six Months Ended
June 30,
 
     2015      2014      2015      2014  

Development milestones earned

   $ —        $ 62,000       $ —        $ 77,000   

Amortization of deferred upfront and development milestones

     846         4,232         2,257         8,465   
  

 

 

    

 

 

    

 

 

    

 

 

 

Total

   $ 846       $ 66,232       $ 2,257       $ 85,465